NAMSA has expanded its microbiology laboratory in Irvine, CA to employ the latest technology for microbiology and sterility assurance testing. Set to open in spring 2013, the new lab space will be used for in vitro toxicology, sterility, and bioburden testing, NAMSA reported in a press release.
Increasing capacity by nearly 50%, the expansion will not affect current services, NAMSA reported.
“At NAMSA, we believe that everything we do must be in our clients’ best interests. This expansion is one of several examples of that commitment,” said Gina Skolmowski, Corporate Vice President of Operations for NAMSA, in the release. “Through this effort we have optimized our processes to meet increased demand for efficient lot release testing.
“The medical device research, regulatory approval and commercialization process is continuously taking longer and costing more, driving the need for efficiencies wherever possible, and we are very focused on helping our clients meet that need,” added Skolmowski.
The building is being improved to meet the requirements of silver Leadership in Energy and Environmental Design (LEED) standards developed by the U.S. Green Building Council (USGBC), NAMSA reported.
For more details visit www.namsa.com .